CAMBRIDGE, Mass.--(BUSINESS WIRE)--Sirtris, a GSK company focused on discovering and developing small molecule drugs to treat diseases of aging such as Type 2 Diabetes, announced today that Christoph Westphal, M.D., Ph.D., Chief Executive Officer of Sirtris, has been awarded Outstanding Individual by his CEO peers in the biotech community at The Laguna Biotech Meeting.
